![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Zhejiang Charioteer Pharmaceutical Co., Ltd. Xianju Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Ganciclovir, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-123 - Rev 01
This Chemical Type CEP, issued on June 20, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1752 associated with this CEP further emphasizes